22916-47-8

• 常用中文名：咪康唑
• 常用英文名：Miconazole
• CAS号：22916-47-8
• 分子式：C₁₈H₁₄Cl₄N₂O
• 分子量：416.129
• 相关类别： 原料药 人工合成抗感染类药 抗真菌类药
• 发布时间：2018-04-05 08:00:00
• 更新时间：2026-06-30 12:22:07
• Miconazole (Monistat)是咪唑类抗真菌剂。

名称

• 中文名: 咪康唑
• 英文名: Miconazole
• 中文别名: 抗 HBV 病毒中间体; 霉康唑; 氯益康唑; 异康唑杂质D; MICONAZOLE标准品; 咪康唑 标准品; R18134|||咪康唑; 乙腈中咪康唑; 1-(2-(2,4-二氯苯基)-2-((2,4-二氯苯基)甲氧基)乙基)-1H-咪唑; 霉可唑; 咪可納唑; Miconazole 咪康唑; 1-(2-((2,4-二氯苄基)氧基)-2-(2,4-二氯苯基)乙基)-1H-咪唑; 咪康唑检测标准品; 咪康唑溶液, 100PPM; 异康唑杂质C(咪康唑); 1-[2-(2,4-二氯苯基)-2-[(2,4-二氯苯基)甲氧基]乙基]-1H-咪唑; 猫咪康唑中间体
• 英文别名: Miconazol; Daktarin IV; MFCD00216019; Desenex; (RS)-1-(2-(2,4-DICHLOROBENZYLOXY)-2-(2,4-DICHLOROPHENYL)ETHYL)-1H-IMIDAZOLE; Monistat; mjr1762; 1-[2,4-DICHLORO-BETA-([2,4-DICHLOROBENZYL]OXY)-PHENETHYL]IMIDAZOLE; micronazol; 1-[2,4-Dichloro-β-[(2,4-dichlorobenzyl)oxy]phenethyl]-1H-imidazole; EINECS 245-324-5; Daktin IV; 1-[2,4-Dichloro-b-[(2,4-dichlorobenzyl)oxy]phenethyl]imidazole; Miconazol gel; (1,2,4-dichlorophenyl)-1H-imidazole-1-Ethanol; Miconazole gel; Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl); Miconazole CRS; MICONAZOLE MM(CRM STANDD); MICONAZOLE (CRM STANDD); Zeasorb-AF; 1-(2,4-Dichlorophenyl)-1-[(2,4-dichlorophenyl)methoxy]-2-(1H-imidazole-1-yl)ethane; Miconazole Nitrate /C; 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole; MICONAZOLE; MONISTAT IV; Miconazole (Monistat); 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1h-imidazole; 1-(2,4-dichloro-β-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole; 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]-1H-imidazole; 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)-imidazol; r18134; Miconozole; (±)-Miconazole; MICONAZOLE FREE BASE; Anti-HBV Virus Intermediate; Feline Miconazole Intermediate; 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-imidazol; 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole; Miconazole (R18134); C15260090 Miconazole; MICONAZOLE BASE; MiconazoleQ: What is Miconazole Q: What is the CAS Number of Miconazole Q: What is the storage condition of Miconazole Q: What e the applications of Miconazole; MICONAZOLE( / STANDD ADE); Isoconazole Impurity D; Minostate; Miconazole Reference Standd; Miconazole (base and/or unspecified salts); Imidazole, 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl); Miconazole //BP; Imidazole, 1-[2,4-dichloro-b-[(2,4-dichlorobenzyl)oxy]phenethyl]- (8CI); 1-{2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole; 1-[2,4-Dichloro-β-(2,4-dichlorobenzyloxy)phenethyl]-1H-imidazole; LABOTEST-BB LT00255845; 1-[2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole; 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- (9CI); Isoconazole IMpurity C (Miconazole)

物化性质

• 密度: 1.4±0.1 g/cm3
• 沸点: 555.1±50.0 °C at 760 mmHg
• 熔点: 159-163ºC
• 分子式: C₁₈H₁₄Cl₄N₂O
• 分子量: 416.129
• 闪点: 289.5±30.1 °C
• 精确质量: 413.986023
• PSA: 27.05000
• LogP: 5.93
• 外观性状: 白色粉末
• 蒸汽压: 0.0±1.4 mmHg at 25°C
• 折射率: 1.625

生物活性

• 描述: Miconazole (Monistat)是咪唑类抗真菌剂。
• 相关类别:
  信号通路 >> 抗感染 >> 真菌
  研究领域 >> 感染
• 参考文献:

  [1]. http://en.wikipedia.org/wiki/Miconazole

MSDS

Material Safety Data Sheet Section1. Identification of the substance Product Name: Miconazole Synonyms: Section2. Hazards identification Harmful by inhalation, in contact with skin, and if swallowed. H302:Harmful if swallowed H317:May cause an allergic skin reaction P261:Avoid breathing dust/fume/gas/mist/vapours/spray P280:Wear protective gloves/protective clothing/eye protection/face protection P301+P312:IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell P363:Wash contaminated clothing before reuse P321:Specific treatment (see on this label) Section3. Composition/information on ingredients. Ingredient name:Miconazole CAS number:22916-47-8 Section4. First aid measures Skin contact:Immediately wash skin with copious amounts of water for at least 15 minutes while removing contaminated clothing and shoes. If irritation persists, seek medical attention. Eye contact:Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical attention. Inhalation:Remove to fresh air. In severe cases or if symptoms persist, seek medical attention. Ingestion:Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention. Section5. Fire fighting measures In the event of a fire involving this material, alone or in combination with other materials, use dry powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus should be worn. Section6. Accidental release measures Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national standards. Respiratory precaution:Wear approved mask/respirator Hand precaution:Wear suitable gloves/gauntlets Skin protection:Wear suitable protective clothing Eye protection:Wear suitable eye protection Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container for disposal. See section 12. Environmental precautions: Do not allow material to enter drains or water courses. Section7. Handling and storage Handling:This product should be handled only by, or under the close supervision of, those properly qualified in the handling and use of potentially hazardous chemicals, who should take into account the fire, health and chemical hazard data given on this sheet. Storage:Store in closed vessels. Section8. Exposure Controls / Personal protection Engineering Controls: Use only in a chemical fume hood. Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles. General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse. Section9. Physical and chemical properties Appearance:Not specified No data Boiling point: Melting point:No data Flash point:No data Density:No data Molecular formula: C18H14Cl4N2O Molecular weight: 416.1 Section10. Stability and reactivity Conditions to avoid: Heat, flames and sparks. Materials to avoid: Oxidizing agents. Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride. Section11. Toxicological information No data. Section12. Ecological information No data. Section13. Disposal consideration Arrange disposal as special waste, by licensed disposal company, in consultation with local waste disposal authority, in accordance with national and regional regulations. Section14. Transportation information Non-harzardous for air and ground transportation. Section15. Regulatory information No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302, or have known CAS numbers that exceed the threshold reporting levels established by SARA Title III, Section 313. SECTION 16 - ADDITIONAL INFORMATION N/A

毒性和生态

CHEMICAL IDENTIFICATION RTECS NUMBER : NI4770000 CHEMICAL NAME : Imidazole, 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)pheneth yl)- CAS REGISTRY NUMBER : 22916-47-8 BEILSTEIN REFERENCE NO. : 0965511 LAST UPDATED : 199806 DATA ITEMS CITED : 14 MOLECULAR FORMULA : C18-H14-Cl4-N2-O MOLECULAR WEIGHT : 416.14 WISWESSER LINE NOTATION : T5N CNJ A1YR BG DG&O1R BG DG HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Human - infant DOSE/DURATION : 104 mg/kg/4D-I TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 550 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 349 mg/kg TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory stimulation TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 105 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 519 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 220 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 90570 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 60 mg/kg TOXIC EFFECTS : Cardiac - other changes TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Mammal - species unspecified DOSE/DURATION : 100 mg/kg TOXIC EFFECTS : Cardiac - other changes TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral DOSE : 800 mg/kg SEX/DURATION : female 15-22 day(s) after conception TOXIC EFFECTS : Reproductive - Maternal Effects - parturition TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral DOSE : 3100 mg/kg SEX/DURATION : female 1-31 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) MUTATION DATA TYPE OF TEST : Sex chromosome loss and nondisjunction TEST SYSTEM : Mold - Aspergillus nidulans DOSE/DURATION : 4160 ug/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 79,169,1980 *** REVIEWS *** TOXICOLOGY REVIEW PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 2,333,1979 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4278 No. of Facilities: 46 (estimated) No. of Industries: 1 No. of Occupations: 3 No. of Employees: 8954 (estimated) No. of Female Employees: 7689 (estimated)

安全

• 符号: GHS07
• 信号词: Warning
• 危害声明: H302-H413
• 警示性声明: P301 + P312 + P330
• 危害码 (欧洲): Xn
• 风险声明 (欧洲): R22
• 安全声明 (欧洲): 22-36
• 危险品运输编码: UN 3249
• 包装等级: III
• 危险类别: 6.1(b)
• 海关编码: 2933290090

合成路线

94-99-5 24155-42-8 ~70% 22916-47-8

文献：Cruz-Almanza, Raymundo; Hernandez, Teresa; Perez, Francisco; Lemini, Cristina Organic Preparations and Procedures International, 1992 , vol. 24, # 3 p. 342 - 345

874-42-0 ~% 22916-47-8

文献：Organic Preparations and Procedures International, , vol. 24, # 3 p. 342 - 345

13692-15-4 ~% 22916-47-8

文献：Organic Preparations and Procedures International, , vol. 24, # 3 p. 342 - 345

上下游产品

上游产品  4
94-99-5 24155-42-8 874-42-0 13692-15-4
下游产品  0

海关

海关编码	2933290090
中文概述	2933290090. 其他结构含非稠合咪唑环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%